Strategies for regeneration of the bone using porcine adult adipose-derived mesenchymal stem cells

Theriogenology

Volumn 75, Issue 8, 2011, Pages 1381-1399

  Monaco, E ^a   Bionaz, M ^a   Hollister, S J ^b   Wheeler, M B ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adipose derived stem cells; Bone marrow mesenchymal stem cells; Mandible; Regenerative medicine; Scaffolds; Stem cell therapy; Swine; Tissue engineering

Indexed keywords

SUIDAE; SUS;

EID: 79953278689     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2010.11.020     Document Type: Review

References (153)

1. Kamboj M.K. Metabolic bone disease in adolescents: recognition, evaluation, treatment, and prevention. Adolesc Med State Art Rev 2007, 18:24-46.
2. Mehta M., Strube P., Peters A., Perka C., Hutmacher D., Fratzl P., Duda G.N. Influences of age and mechanical stability on volume, microstructure, and mineralization of the fracture callus during bone healing: is osteoclast activity the key to age-related impaired healing?. Bone 2010, 47:219-228.
3. Schmitz J.P., Hollinger J.O. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986, 205:299-308.
4. Hollinger J.O., Kleinschmidt J.C. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990, 1:60-68.
5. Habal M.B., Reddi A.H. Bone grafts and bone induction substitutes. Clin Plast Surg 1994, 21:525-542.
6. Brevi B.C., Magri A.S., Toma L., Sesenna E. Cranioplasty for repair of a large bone defect with autologous and homologous bone in children. J Pediatr Surg 2010, 45:E17-E20.
7. Conway J.D. Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft. Orthop Clin North Am 2010, 41:75-84.
8. Kohn D., Sander-Beuermann A. Donor-site morbidity after harvest of a bone-tendon-bone patellar tendon autograft. Knee Surg Sports Traumatol Arthrosc 1994, 2:219-223.
9. Grayson W.L., Frohlich M., Yeager K., Bhumiratana S., Chan M.E., Cannizzaro C., Wan L.Q., Liu X.S., Guo X.E., Vunjak-Novakovic G. Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci USA 2010, 107:3299-3304.
10. Khan S.N., Cammisa F.P., Sandhu H.S., Diwan A.D., Girardi F.P., Lane J.M. The biology of bone grafting. J Am Acad Orthop Surg 2005, 13:77-86.
11. Laurencin C 2003, ASTM international, Bone Graft Substitutes.
12. Barone C.M. Craniofacial reconstruction. Clin Plast Surg 2004, 31:ix.
13. Whitaker M.J., Quirk R.A., Howdle S.M., Shakesheff K.M. Growth factor release from tissue engineering scaffolds. J Pharm Pharmacol 2001, 53:1427-1437.
14. Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., Ikada Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J Control Release 2000, 64:133-142.
15. Sheridan M.H., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000, 64:91-102.
16. Jansen J.A., Vehof J.W., Ruhe P.Q., Kroeze-Deutman H., Kuboki Y., Takita H., Hedberg E.L., Mikos A.G. Growth factor-loaded scaffolds for bone engineering. J Control Release 2005, 101:127-136.
17. Srouji S., Rachmiel A., Blumenfeld I., Livne E. Mandibular defect repair by TGF-beta and IGF-1 released from a biodegradable osteoconductive hydrogel. J Craniomaxillofac Surg 2005, 33:79-84.
18. Vacanti J.P., Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999, 354(Suppl 1):SI32-SI34.
19. Hollister S.J., Lin C.Y., Saito E., Schek R.D., Taboas J.M., Williams J.M., Partee B., Flanagan C.L., Diggs A., Wilke E.N., Van Lenthe G.H., Muller R., Wirtz T., Das S., Feinberg S.E., Krebsbach P.H. Engineering craniofacial scaffolds. Orthod Craniofac Res 2005, 8:162-173.
20. Kimelman N., Pelled G., Helm G.A., Huard J., Schwarz E.M., Gazit D. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007, 13:1135-1150.
21. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36(Suppl 3):S20-S27.
22. Ahlmann E., Patzakis M., Roidis N., Shepherd L., Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002, 84-A:716-720.
23. Slynarski K., Deszczynski J., Karpinski J. Fresh bone marrow and periosteum transplantation for cartilage defects of the knee. Transplant Proc 2006, 38:318-319.
24. Veyrat-Masson R., Boiret-Dupre N., Rapatel C., Descamps S., Guillouard L., Guerin J.J., Pigeon P., Boisgard S., Chassagne J., Berger M.G. Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy. Br J Haematol 2007, 139:312-320.
25. Stamm C., Kleine H.D., Choi Y.H., Dunkelmann S., Lauffs J.A., Lorenzen B., David A., Liebold A., Nienaber C., Zurakowski D., Freund M., Steinhoff G. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007, 133:717-725.
26. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002, 99:8932-8937.
27. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976, 4:267-274.
28. Sudo K., Kanno M., Miharada K., Ogawa S., Hiroyama T., Saijo K., Nakamura Y. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells 2007, 25:1610-1617.
29. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
30. Sensebe L., Krampera M., Schrezenmeier H., Bourin P., Giordano R. Mesenchymal stem cells for clinical application. Vox Sang 2010, 98:93-107.
31. Deschaseaux F., Sensebe L., Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med 2009, 15:417-429.
32. DelaRosa O., Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm 2010, 2010:865601.
33. Ghannam S., Bouffi C., Djouad F., Jorgensen C., Noel D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 2010, 1:2.
34. Meirelles Lda S., Fontes A.M., Covas D.T., Caplan A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009, 20:419-427.
35. Schindeler A., Liu R., Little D.G. The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation 2009, 77:12-18.
36. Zaidi N., Nixon A.J. Stem cell therapy in bone repair and regeneration. Ann N Y Acad Sci 2007, 1117:62-72.
37. Leucht P., Kim J.B., Amasha R., James A.W., Girod S., Helms J.A. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 2008, 135:2845-2854.
38. Meijer G.J., de Bruijn J.D., Koole R., van Blitterswijk C.A. Cell based bone tissue engineering in jaw defects. Biomaterials 2008, 29:3053-3061.
39. Kulakov A.A., Goldshtein D.V., Grigoryan A.S., Rzhaninova A.A., Alekseeva I.S., Arutyunyan I.V., Volkov A.V. Clinical study of the efficiency of combined cell transplant on the basis of multipotent mesenchymal stromal adipose tissue cells in patients with pronounced deficit of the maxillary and mandibulary bone tissue. Bull Exp Biol Med 2008, 146:522-525.
40. Levi B., James A.W., Nelson E.R., Vistnes D., Wu B., Lee M., Gupta A., Longaker M.T. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 2010, 5:e11177.
41. Rada T., Reis R.L., Gomes M.E. Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev 2009, 15:113-125.
42. Yoshimura K., Shigeura T., Matsumoto D., Sato T., Takaki Y., Aiba-Kojima E., Sato K., Inoue K., Nagase T., Koshima I., Gonda K. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006, 208:64-76.
43. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
44. Bredeson C., Leger C., Couban S., Simpson D., Huebsch L., Walker I., Shore T., Howson-Jan K., Panzarella T., Messner H., Barnett M., Lipton J. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biol Blood Marrow Transplant 2004, 10:405-414.
45. Monaco E., Lima A., Bionaz M., Makia A., Hurley W.L., Wheeler M.B. Morphological and Transcriptomic Comparison of Adipose and Bone Marrow Derived Porcine Stem Cells. J Tissue Eng Regen Med 2009, 2:20-33.
46. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch 2009, 76:56-66.
47. Williams K.J., Picou A.A., Kish S.L., Giraldo A.M., Godke R.A., Bondioli K.R. Isolation and characterization of porcine adipose tissue-derived adult stem cells. Cells Tissues Organs 2008, 188:251-258.
48. Arrigoni E., Lopa S., de Girolamo L., Stanco D., Brini A.T. Isolation, characterization and osteogenic differentiation of adipose-derived stem cells: from small to large animal models. Cell Tissue Res 2009, 338:401-411.
49. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970, 3:393-403.
50. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
51. Guo Z., Li H., Li X., Yu X., Wang H., Tang P., Mao N. In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 2006, 24:992-1000.
52. Kuhn N.Z., Tuan R.S. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 2010, 222:268-277.
53. Shoji T., Ii M., Mifune Y., Matsumoto T., Kawamoto A., Kwon S.M., Kuroda T., Kuroda R., Kurosaka M., Asahara T. Local transplantation of human multipotent adipose-derived stem cells accelerates fracture healing via enhanced osteogenesis and angiogenesis. Lab Invest 2010, 90:637-649.
54. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
55. Marot D., Knezevic M., Novakovic G.V. Bone tissue engineering with human stem cells. Stem Cell Res Ther 2010, 1:10.
56. Baglioni S., Francalanci M., Squecco R., Lombardi A., Cantini G., Angeli R., Gelmini S., Guasti D., Benvenuti S., Annunziato F., Bani D., Liotta F., Francini F., Perigli G., Serio M., Luconi M. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 2009, 23:3494-3505.
57. Jurgens W.J., Oedayrajsingh-Varma M.J., Helder M.N., Zandiehdoulabi B., Schouten T.E., Kuik D.J., Ritt M.J., van Milligen F.J. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell Tissue Res 2008, 332:415-426.
58. Pittenger M.F., Mosca J.D., McIntosh K.R. Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol 2000, 251:3-11.
59. Aust L., Devlin B., Foster S.J., Halvorsen Y.D., Hicok K., du Laney T., Sen A., Willingmyre G.D., Gimble J.M. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 2004, 6:7-14.
60. D'Ippolito G., Schiller P.C., Ricordi C., Roos B.A., Howard G.A. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999, 14:1115-1122.
61. Zhang Y., Bellows C., Simmons P., Khalsa A., Kolonin M. Circulation of progenitor and endothelial cells in obese patients: the contribution of adipose tissue. ISSCR 8th Annual Meeting, San Francisco 2010, K16.
62. Wahl P., Brixius K., Bloch W. Exercise-induced stem cell activation and its implication for cardiovascular and skeletal muscle regeneration. Minim Invasive Ther Allied Technol 2008, 17:91-99.
63. Sakurai T., Endo S., Hatano D., Ogasawara J., Kizaki T., Oh-Ishi S., Izawa T., Ishida H., Ohno H. Effects of exercise training on adipogenesis of stromal-vascular fraction cells in rat epididymal white adipose tissue. Acta Physiol (Oxf) 2010.
64. Lima A.S., Malusky S.A., Mello M.R.B., Lane S.J., Rivera J.R., Wheeler M.B. Transplantation and in vivo differentiation of adipose-derived stem cells in swine. Reprod Fertil Devel 2006, 18:208.
65. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
66. Liu T.M., Martina M., Hutmacher D.W., Hui J.H., Lee E.H., Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007, 25:750-760.
67. Milner D.J., Bionaz M., Monaco E., Cameron J.A., Wheeler M.B. Assessing and Enhancing the Myogenic Differentiation Capability of Adult Porcine Adipose-Derived Stem Cells 2010, ISSCR 8th Annual Meeting, San Francisco.
68. Safford K.M., Hicok K.C., Safford S.D., Halvorsen Y.D., Wilkison W.O., Gimble J.M., Rice H.E. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002, 294:371-379.
69. Ashjian P.H., Elbarbary A.S., Edmonds B., DeUgarte D., Zhu M., Zuk P.A., Lorenz H.P., Benhaim P., Hedrick M.H. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 2003, 111:1922-1931.
70. Cao Y., Sun Z., Liao L., Meng Y., Han Q., Zhao R.C. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005, 332:370-379.
71. Planat-Benard V., Silvestre J.S., Cousin B., Andre M., Nibbelink M., Tamarat R., Clergue M., Manneville C., Saillan-Barreau C., Duriez M., Tedgui A., Levy B., Penicaud L., Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109:656-663.
72. Seo M.J., Suh S.Y., Bae Y.C., Jung J.S. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005, 328:258-264.
73. Talens-Visconti R., Bonora A., Jover R., Mirabet V., Carbonell F., Castell J.V., Gomez-Lechon M.J. Human mesenchymal stem cells from adipose tissue: Differentiation into hepatic lineage. Toxicol In Vitro 2007, 21:324-329.
74. Timper K., Seboek D., Eberhardt M., Linscheid P., Christ-Crain M., Keller U., Muller B., Zulewski H. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006, 341:1135-1140.
75. Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 2008, 15:53-76.
76. Gronthos S., Franklin D.M., Leddy H.A., Robey P.G., Storms R.W., Gimble J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001, 189:54-63.
77. Mosna F., Sensebe L., Krampera M. Human Bone-Marrow And Adipose Tissue Mesenchymal Stem Cells: A User's Guide. Stem Cells Dev 2010.
78. Noel D., Caton D., Roche S., Bony C., Lehmann S., Casteilla L., Jorgensen C., Cousin B. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Experimental Cell Research 2008, 314:1575-1584.
79. Katz A.J., Tholpady A., Tholpady S.S., Shang H., Ogle R.C. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005, 23:412-423.
80. Jorgensen C., Djouad F., Apparailly F., Noel D. Engineering mesenchymal stem cells for immunotherapy. Gene Ther 2003, 10:928-931.
81. Shi Y., Hu G., Su J., Li W., Chen Q., Shou P., Xu C., Chen X., Huang Y., Zhu Z., Huang X., Han X., Xie N., Ren G. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010, 20:510-518.
82. Gangenahalli G.U., Singh V.K., Verma Y.K., Gupta P., Sharma R.K., Chandra R., Luthra P.M. Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev 2006, 15:305-313.
83. Lin G., Garcia M., Ning H., Banie L., Guo Y.L., Lue T.F., Lin C.S. Defining Stem and Progenitor Cells within Adipose Tissue. Stem Cells and Development 2008, 17:1053-1063.
84. Unclassified data found in reference [Bionaz M, Tor J, Monaco E, Dymon Z, Maki AJ, Hurley WL, Wheeler MB. In vitro osteogenic differentiation and in vivo healing capacity of porcine CD34+ adipose-derived stem cells. ISSCR 8th Annual Meeting, San Francisco, 2010].
85. Lin C.S., Xin Z.C., Deng C.H., Ning H., Lin G., Lue T.F. Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol 2010, 25:807-815.
86. Layton D.S., Strom A.D., O'Neil T.E., Broadway M.M., Stephenson G.L., Morris K.R., Muralitharan M., Sandrin M.S., Ierino F.L., Bean A.G. Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells. Exp Hematol 2007, 35:171-178.
87. Jansen B.J., Gilissen C., Roelofs H., Schaap-Oziemlak A., Veltman J.A., Raymakers R.A., Jansen J.H., Kogler G., Figdor C.G., Torensma R., Adema G.J. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 2010, 19:481-490.
88. Unclassified data found in reference [Monaco E, Lima A, Wilson S, Kim D, Bionaz M, Hurley WL, Wheeler MB. Temporal Transcript Profiling of Porcine Adult Mesenchymal Stem Cells during Osteogenic and Adipogenic Differentiation using a 13K Porcine Microarray. ISSCR 6th Annual Meeting, Philadelphia, 2008].
89. Monaco E., Bionaz M., Lima A., Hurley W.L., Wheeler M.B. ADSC and BMSC present large similarities in transcriptome prior to and during adipogenic and osteogenic differentiation. Reprod Fertil Devel 2010, 23. (In press).
90. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
91. Huang da W., Sherman B.T., Zheng X., Yang J., Imamichi T., Stephens R., Lempicki R.A. Extracting biological meaning from large gene lists with DAVID. Curr Protoc Bioinformatics 2009, Chapter 13: Unit 13 11.
92. Monaco E., Sobreira de Lima A., Bionaz M., Maki A., Wilson M.S., Hurley W.L., Wheeler M.B. Morphological and Transcriptomic Comparison of Adipose and Bone Marrow Derived Porcine Stem Cells. Open Tiss Eng Regen Med J 2009, 2:20-33.
93. Dwyer R.M., Kerin M.J. Mesenchymal Stem Cells (MSCs) and Cancer: tumour specific delivery vehicles or therapeutic targets?. Hum Gene Ther 2010.
94. Spaeth E., Klopp A., Dembinski J., Andreeff M., Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008, 15:730-738.
95. Sokolova I.B., Zin'kova N.N., Shvedova E.V., Kruglyakov P.V., Polyntsev D.G. Distribution of mesenchymal stem cells in the area of tissue inflammation after transplantation of the cell material via different routes. Bull Exp Biol Med 2007, 143:143-146.
96. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 2010, 5:e10088.
97. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
98. Liu Z.J., Zhuge Y., Velazquez O.C. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 2009, 106:984-991.
99. Mishima Y., Lotz M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 2008, 26:1407-1412.
100. Li Y., Yu X., Lin S., Li X., Zhang S., Song Y.H. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 2007, 356:780-784.
101. Meng E., Guo Z., Wang H., Jin J., Wang J., Wu C., Wang L. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev 2008, 17:805-813.
102. Kucia M., Wojakowski W., Reca R., Machalinski B., Gozdzik J., Majka M., Baran J., Ratajczak J., Ratajczak M.Z. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch Immunol Ther Exp (Warsz) 2006, 54:121-135.
103. Stich S., Loch A., Leinhase I., Neumann K., Kaps C., Sittinger M., Ringe J. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur J Cell Biol 2008, 87:365-376.
104. Trubiani O., Isgro A., Zini N., Antonucci I., Aiuti F., Di Primio R., Nanci A., Caputi S., Paganelli R. Functional interleukin-7/interleukin-7Ralpha, and SDF-1alpha/CXCR4 are expressed by human periodontal ligament derived mesenchymal stem cells. J Cell Physiol 2008, 214:706-713.
105. Cho H.H., Kyoung K.M., Seo M.J., Kim Y.J., Bae Y.C., Jung J.S. Overexpression of CXCR4 increases migration and proliferation of human adipose tissue stromal cells. Stem Cells Dev 2006, 15:853-864.
106. Sengenes C., Miranville A., Maumus M., de Barros S., Busse R., Bouloumie A. Chemotaxis and differentiation of human adipose tissue CD34+/CD31- progenitor cells: role of stromal derived factor-1 released by adipose tissue capillary endothelial cells. Stem Cells 2007, 25:2269-2276.
107. Gehmert S., Prantl L., Vykoukal J., Alt E., Song Y.H. Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/PDGFR-beta signaling pathway. Biochem Biophys Res Commun 2010.
108. Abramsson A., Lindblom P., Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 2003, 112:1142-1151.
109. Furuhashi M., Sjoblom T., Abramsson A., Ellingsen J., Micke P., Li H., Bergsten-Folestad E., Eriksson U., Heuchel R., Betsholtz C., Heldin C.H., Ostman A. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res 2004, 64:2725-2733.
110. Amos P.J., Shang H., Bailey A.M., Taylor A., Katz A.J., Peirce S.M. IFATS collection: The role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 2008, 26:2682-2690.
111. Wilson S. Analysis of the therapeutic potential, migration, and possible tumor formation associated with porcine adipose-derived mesenchymal stem cell transplantation, Animal Sciences 2009, University of Illinois, Urbana, 130.
112. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31:890-896.
113. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
114. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
115. Crop M., Baan C.C., Korevaar S.S., Ijzermans J.N., Weimar W., Hoogduijn M.J. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 2010.
116. Jones B.J., McTaggart S.J. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 2008, 36:733-741.
117. Yanez R., Lamana M.L., Garcia-Castro J., Colmenero I., Ramirez M., Bueren J.A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006, 24:2582-2591.
118. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
119. Voog J., Jones D.L. Stem cells and the niche: a dynamic duo. Cell Stem Cell 2010, 6:103-115.
120. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., Tallquist M.D., Graff J.M. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322:583-586.
121. Carrion B., Huang C.P., Ghajar C.M., Kachgal S., Kniazeva E., Jeon N.L., Putnam A.J. Recreating the perivascular niche ex vivo using a microfluidic approach. Biotechnol Bioeng 2010.
122. Duggal S., Fronsdal K.B., Szoke K., Shahdadfar A., Melvik J.E., Brinchmann J.E. Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds. Tissue Eng Part A 2009, 15:1763-1773.
123. Cowan C.M., Shi Y.Y., Aalami O.O., Chou Y.F., Mari C., Thomas R., Quarto N., Contag C.H., Wu B., Longaker M.T. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004, 22:560-567.
124. Dudas J.R., Marra K.G., Cooper G.M., Penascino V.M., Mooney M.P., Jiang S., Rubin J.P., Losee J.E. The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects. Ann Plast Surg 2006, 56:543-548.
125. Kim D., Monaco E., Maki A., de Lima A.S., Kong H.J., Hurley W.L., Wheeler M.B. Morphologic and transcriptomic comparison of adipose- and bone-marrow-derived porcine stem cells cultured in alginate hydrogels. Cell Tissue Res 2010, 341:359-370.
126. Unclassified data found in reference [Dongshin K, Monaco E, Aaron M, Lima A, Kong H, Hurley WL, Wheeler MB. Morphologic and transcriptomic comparison of adipose- and bone-marrow-derived porcine stem cells cultured in alginate hydrogels. Cell Tissue Res 2010;(In press)].
127. Carano R.A., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 2003, 8:980-989.
128. Lee J.A., Parrett B.M., Conejero J.A., Laser J., Chen J., Kogon A.J., Nanda D., Grant R.T., Breitbart A.S. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 2003, 50:610-617.
129. Hicok K.C., Du Laney T.V., Zhou Y.S., Halvorsen Y.D., Hitt D.C., Cooper L.F., Gimble J.M. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004, 10:371-380.
130. Cui L., Liu B., Liu G., Zhang W., Cen L., Sun J., Yin S., Liu W., Cao Y. Repair of cranial bone defects with adipose derived stem cells and coral scaffold in a canine model. Biomaterials 2007, 28:5477-5486.
131. Follmar K.E., Prichard H.L., DeCroos F.C., Wang H.T., Levin L.S., Klitzman B., Olbrich K.C., Erdmann D. Combined bone allograft and adipose-derived stem cell autograft in a rabbit model. Ann Plast Surg 2007, 58:561-565.
132. 1993, NIH, U.S. National Institute of Health: U.S. National Institutes of Health. http://ClinicalTrials.gov.
133. Wilson S.M., Monaco E., Goldwasser M.S., Clark S.G., Hurley W.L., Wheeler M.B. Migration and Therapeutic Potential of Porcine Adult Adipose-Derived Mesenchymal Stem Cells. Reprod Fertil Devel 2010, 22:357.
134. de Groot K., Wolke J.G., Jansen J.A. Calcium phosphate coatings for medical implants. Proc Inst Mech Eng H 1998, 212:137-147.
135. Kokubo T., Kim H.M., Kawashita M. Novel bioactive materials with different mechanical properties. Biomaterials 2003, 24:2161-2175.
136. Habibovic P., Li J., van der Valk C.M., Meijer G., Layrolle P., van Blitterswijk C.A., de Groot K. Biological performance of uncoated and octacalcium phosphate-coated Ti6Al4V. Biomaterials 2005, 26:23-36.
137. Ogino M., Ohuchi F., Hench L.L. Compositional dependence of the formation of calcium phosphate films on bioglass. J Biomed Mater Res 1980, 14:55-64.
138. Murphy W.L., Kohn D.H., Mooney D.J. Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro. J Biomed Mater Res 2000, 50:50-58.
139. Murphy W.L., Mooney D.J. Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata. J Am Chem Soc 2002, 124:1910-1917.
140. Suarez-Gonzalez D., Barnhart K., Saito E., Vanderby R., Hollister S.J., Murphy W.L. Controlled nucleation of hydroxyapatite on alginate scaffolds for stem cell-based bone tissue engineering. J Biomed Mater Res A 2010.
141. Segvich S., Smith H.C., Luong L.N., Kohn D.H. Uniform deposition of protein incorporated mineral layer on three-dimensional porous polymer scaffolds. J Biomed Mater Res B Appl Biomater 2008, 84:340-349.
142. Rai B., Teoh S.H., Hutmacher D.W., Cao T., Ho K.H. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005, 26:3739-3748.
143. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., Chen J., Vunjak-Novakovic G., Kaplan D.L. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 2006, 78:324-334.
144. Liu H.W., Chen C.H., Tsai C.L., Lin I.H., Hsiue G.H. Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng 2007, 13:1113-1124.
145. Park Y.J., Kim K.H., Lee J.Y., Ku Y., Lee S.J., Min B.M., Chung C.P. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol Appl Biochem 2006, 43:17-24.
146. Zhao Y., Zhang J., Wang X., Chen B., Xiao Z., Shi C., Wei Z., Hou X., Wang Q., Dai J. The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies. J Control Release 2010, 141:30-37.
147. Gharibjanian N.A., Chua W.C., Dhar S., Scholz T., Shibuya T.Y., Evans G.R., Calvert J.W. Release kinetics of polymer-bound bone morphogenetic protein-2 and its effects on the osteogenic expression of MC3T3-E1 osteoprecursor cells. Plast Reconstr Surg 2009, 123:1169-1177.
148. Zhang H., Migneco F., Lin C.Y., Hollister S.J. Chemically-Conjugated Bone Morphogenetic Protein-2 on Three-Dimensional Polycaprolactone Scaffolds Stimulates Osteogenic Activity in Bone Marrow Stromal Cells. Tissue Eng Part A 2010.
149. Kuboki Y., Jin Q., Kikuchi M., Mamood J., Takita H. Geometry of artificial ECM: sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis. Connect Tissue Res 2002, 43:529-534.
150. Kuhne J.H., Bartl R., Frisch B., Hammer C., Jansson V., Zimmer M. Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits. Acta Orthop Scand 1994, 65:246-252.
151. Schek R.M., Wilke E.N., Hollister S.J., Krebsbach P.H. Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering. Biomaterials 2006, 27:1160-1166.
152. Hui P.W., Leung P.C., Sher A. Fluid conductance of cancellous bone graft as a predictor for graft-host interface healing. J Biomech 1996, 29:123-132.
153. Jones A.C., Arns C.H., Hutmacher D.W., Milthorpe B.K., Sheppard A.P., Knackstedt M.A. The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 2009, 30:1440-1451.